Aadi Bioscience's total assets for Q3 2024 were $85.70M, a decrease of -15.67% from the previous quarter. AADI total liabilities were $16.83M for the fiscal quarter, a -26.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.